Eli Lilly Expects Mounjaro's Leadership to Continue -- Market Talk
Dow Jones2026/10/29 15:551155 ET - Eli Lilly expects its diabetes drug Mounjaro to maintain its leadership in the U.S., finance chief Lucas Montarce says during a call with analysts. In the latest quarter, Mounjaro's U.S. revenue gained 41% to $5 billion. Montarce also pointed to strength for Mounjaro outside of the U.S. in the period, with those sales up 93% to $5.7 billion. Overall, Mounjaro sales gained 65% to $10.72 billion in the quarter. (kelly.cloonan@wsj.com)
(END) Dow Jones Newswires
October 29, 2026 11:55 ET (15:55 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Uniswap StablePair pool adjusts fees based on price deviation
Markus Thielen predicts bitcoin will reach $90,000 by the end of the year
Crypto prices
More
